Patients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab
Autor: | Arsène Mekinian, Véronique Le Guern, Cécile Yelnik, Eric Hachulla, Thomas Quemeneur, Marie Frimat, Sébastien Miranda, Estibaliz Lazaro, François Provôt, Nathalie Costedoat-Chalumeau, Sandrine Morell-Dubois, Marc Lambert |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Male medicine.medical_specialty Multiple Organ Failure Immunology Drug Resistance Antibodies Monoclonal Humanized Catastrophic antiphospholipid syndrome Biochemistry Refractory Renal Dialysis medicine Humans Catastrophic Illness Intensive care medicine Retrospective Studies Venous Thrombosis business.industry Immunoglobulins Intravenous Cell Biology Hematology Middle Aged Eculizumab Antiphospholipid Syndrome Combined Modality Therapy Kidney Transplantation Thrombocytopenia Complement Inactivating Agents Treatment Outcome Female Rituximab business medicine.drug |
Zdroj: | Blood. 136:2473-2477 |
ISSN: | 1528-0020 0006-4971 |
DOI: | 10.1182/blood.2020007499 |
Databáze: | OpenAIRE |
Externí odkaz: |